Showing results (6701-6710 of 10,083) with videos related to
Sort By:
Pageof 1,009
Current Pharmaceutical Design|June 13, 2009
Curcumin has bright prospects for the treatment of inflammatory bowel diseaseHiroyuki Hanai, Ken SugimotoCurrent Pharmaceutical Design|January 9, 2009
Non-invasive diagnostic tools for investigating endothelial dysfunctionLorenzo Ghiadoni, Daniele Versari, Chiara Giannarelli, et al.Current Pharmaceutical Design|January 9, 2009
The mineralocorticoid receptor in endothelial physiology and disease: novel concepts in the understanding of erectile dysfunctionMassimiliano Caprio, Caterina Mammi, Iris Z Jaffe, et al.Current Pharmaceutical Design|January 9, 2009
Drugs designed to improve endothelial function: effects on erectile dysfunctionA W Shindel, S Kishore, T F LueCurrent Pharmaceutical Design|January 9, 2009
Endothelial effects of drugs designed to treat erectile dysfunctionAntonio Aversa, Massimiliano Caprio, Giuseppe M C Rosano, et al.Current Pharmaceutical Design|January 9, 2009
Pigment epithelium-derived factor prevents melanoma growth via angiogenesis inhibitionRiichiro Abe, Yasuyuki Fujita, Sho-ichi Yamagishi, et al.Current Pharmaceutical Design|January 9, 2009
Color-coded fluorescent protein imaging of angiogenesis: the AngioMouse modelsYasuyuki Amoh, Kensei Katsuoka, Robert M HoffmanCurrent Pharmaceutical Design|January 9, 2009
Subtype selectivity in phosphodiesterase 4 (PDE4): a bottleneck in rational drug designP Srivani, D Usharani, Eluvathingal D Jemmis, et al.Current Pharmaceutical Design|February 10, 2009
Encountering and advancing through antiangiogenesis therapy for gliomasVanesa Martin, Dan Liu, Candelaria Gomez-ManzanoCurrent Pharmaceutical Design|February 10, 2009
PI-3 kinase-PTEN signaling node: an intercept point for the control of angiogenesisR C Castellino, C R Muh, D L DurdenPageof 1,009